- Home
- ARMP vs KTF Comparison
ARMP vs KTF Comparison
Compare ARMP & KTF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ARMP | KTF |
|---|---|---|
| Founded | N/A | 1988 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 383.7M | 359.6M |
| IPO Year | 1996 | N/A |
Fundamental Metrics
Financial Performance| Metric | ARMP | KTF |
|---|---|---|
| Price | $11.31 | $9.15 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $15.00 | N/A |
| AVG Volume (30 Days) | 49.2K | ★ 155.1K |
| Earning Date | 05-13-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 3.54% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.39 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $23.44 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.17 | $8.48 |
| 52 Week High | $14.98 | $9.37 |
Technical Indicators
Market Signals| Indicator | ARMP | KTF |
|---|---|---|
| Relative Strength Index (RSI) | 48.53 | 52.96 |
| Support Level | $5.14 | $9.13 |
| Resistance Level | $12.11 | $9.27 |
| Average True Range (ATR) | 1.40 | 0.05 |
| MACD | -0.00 | 0.00 |
| Stochastic Oscillator | 30.02 | 50.00 |
Price Performance
Historical ComparisonAbout ARMP Armata Pharmaceuticals Inc.
Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. The company is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck, the company is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent.
About KTF DWS Municipal Income Trust
DWS Municipal Income Trust is a closed-ended fixed income mutual fund launched and managed by Deutsche Investment Management Americas, Inc. The company invests in the fixed income markets of the United States. The fund invests in investment-grade tax-exempt municipal securities which are exempt from federal income tax. The fund benchmarks the performance of its portfolio against the Barclays Municipal Bond Index. The Fund invests in various states, such as Texas, Florida, Pennsylvania, Illinois, and California.